Variant report

Variant	esv3367779
Chromosome Location	chr2:134023582-134025680
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:229)
CpG islands
(count:366)
Chromatin interactive
region (count:3)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:229 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:134022701-134024075	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr2:134023525-134024142	A549	lung:	n/a	n/a
3	BCL3	chr2:134023499-134024135	A549	lung:	n/a	n/a
4	BRCA1	chr2:134022507-134023986	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr2:134024047-134024339	IMR90	lung:	n/a	chr2:134024205-134024216
6	CEBPB	chr2:134022735-134025209	Hela-S3	cervix:	n/a	chr2:134024205-134024216
7	CHD2	chr2:134022615-134025069	Hela-S3	cervix:	n/a	chr2:134023449-134023456 chr2:134024118-134024128 chr2:134023183-134023193
8	CHD2	chr2:134023798-134024368	H1-hESC	embryonic stem cell:	n/a	chr2:134024118-134024128
9	CTBP2	chr2:134022993-134024496	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr2:134024220-134024370	AG04449	skin:	n/a	n/a
11	CTCF	chr2:134023875-134023882	Fibrobl	skin:	n/a	n/a
12	CTCF	chr2:134023760-134023910	AG04450	lung:	n/a	n/a
13	CTCF	chr2:134023840-134023990	HFF	foreskin:	n/a	n/a
14	CTCF	chr2:134024680-134024830	HBMEC	blood vessel:	n/a	n/a
15	CTCF	chr2:134023720-134023870	WI-38	lung:	n/a	n/a
16	CTCF	chr2:134023780-134023930	HEEpiC	esophagus:	n/a	n/a
17	CTCF	chr2:134023740-134023890	AG04450	lung:	n/a	n/a
18	CTCF	chr2:134023780-134023930	MCF-7	breast:	n/a	n/a
19	CTCF	chr2:134023723-134023922	NHEK	skin:	n/a	n/a
20	CTCF	chr2:134023777-134023953	MCF-7	breast:	n/a	n/a
21	CTCF	chr2:134023780-134023930	A549	lung:	n/a	n/a
22	CTCF	chr2:134023697-134024032	IMR90	lung:	n/a	n/a
23	CTCF	chr2:134023440-134023590	GM12872	blood:	n/a	n/a
24	CTCF	chr2:134023840-134023990	HCPEpiC	choroid plexus:	n/a	n/a
25	CTCF	chr2:134024253-134024298	MCF-7	breast:	n/a	n/a
26	CTCF	chr2:134023780-134023930	HMEC	breast:	n/a	n/a
27	CTCF	chr2:134024240-134024390	WERI-Rb-1	eye:	n/a	n/a
28	CTCF	chr2:134023760-134023910	A549	lung:	n/a	n/a
29	CTCF	chr2:134023800-134023950	GM12872	blood:	n/a	n/a
30	CTCF	chr2:134023124-134024240	A549	lung:	n/a	chr2:134023325-134023338 chr2:134023331-134023344 chr2:134024038-134024051 chr2:134024111-134024124
31	CTCF	chr2:134023800-134023950	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr2:134023929-134023968	Lung_OC	lung:	n/a	n/a
33	CTCF	chr2:134023780-134023930	NHLF	lung:	n/a	n/a
34	CTCF	chr2:134023740-134023890	BJ	skin:	n/a	n/a
35	CTCF	chr2:134023782-134023859	Fibrobl	skin:	n/a	n/a
36	CTCF	chr2:134023780-134023930	HA-sp	spinal cord:	n/a	n/a
37	CTCF	chr2:134025600-134025750	HPF	lung:	n/a	n/a
38	CTCF	chr2:134023680-134023830	HAc	cerebellar:	n/a	n/a
39	CTCF	chr2:134024080-134024230	NHDF-neo	bronchial:	n/a	chr2:134024111-134024124
40	CTCF	chr2:134023820-134023970	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr2:134023780-134023930	GM12872	blood:	n/a	n/a
42	CTCF	chr2:134023760-134023910	HCFaa	heart:	n/a	n/a
43	CTCF	chr2:134023820-134023970	GM12872	blood:	n/a	n/a
44	CTCF	chr2:134023760-134023910	AoAF	blood vessel:	n/a	n/a
45	CTCF	chr2:134023720-134023870	GM12868	blood:	n/a	n/a
46	CTCF	chr2:134023920-134024070	GM12874	blood:	n/a	chr2:134024038-134024051
47	CTCF	chr2:134023840-134023990	WERI-Rb-1	eye:	n/a	n/a
48	CTCF	chr2:134024036-134024049	MCF-7	breast:	n/a	n/a
49	CTCF	chr2:134023780-134023930	GM12867	blood:	n/a	n/a
50	CTCF	chr2:134023820-134023970	HUVEC	blood vessel:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:134024093-134024143	GM06990	blood:	n/a
2	chr2:134024459-134024509	HMEC	breast:	n/a
3	chr2:134024093-134024143	HRCEpiC	kidney:	n/a
4	chr2:134024459-134024509	HRPEpiC	eye:	n/a
5	chr2:134024266-134024316	CMK	blood:	n/a
6	chr2:134023662-134023712	AoSMC	blood vessel:	n/a
7	chr2:134024093-134024143	HCPEpiC	choroid plexus:	n/a
8	chr2:134023662-134023712	BJ	skin:	n/a
9	chr2:134024418-134024468	HNPCEpiC	eye:	n/a
10	chr2:134024266-134024316	Jurkat	blood:	n/a
11	chr2:134024266-134024316	GM12891	blood:	n/a
12	chr2:134024093-134024143	ProgFib	skin:	n/a
13	chr2:134024418-134024468	GM12891	blood:	n/a
14	chr2:134024093-134024143	GM12878	blood:	n/a
15	chr2:134024418-134024468	H1-hESC	embryonic stem cell:	embryo
16	chr2:134024618-134024668	HCT-116	colon:	n/a
17	chr2:134024459-134024509	HepG2	liver:	n/a
18	chr2:134024266-134024316	PrEC	prostate:	n/a
19	chr2:134024093-134024143	BE2_C	brain:	n/a
20	chr2:134024418-134024468	Caco-2	colon:	n/a
21	chr2:134024093-134024143	SK-N-MC	brain:	n/a
22	chr2:134024418-134024468	HAEpiC	amniotic membrane:	n/a
23	chr2:134024418-134024468	AG09309	skin:	n/a
24	chr2:134024093-134024143	SAEC	small airway:	n/a
25	chr2:134024266-134024316	NB4	blood:	n/a
26	chr2:134024459-134024509	HCM	heart:	n/a
27	chr2:134024266-134024316	GM06990	blood:	n/a
28	chr2:134024266-134024316	HEK293	kidney:	embryo
29	chr2:134024618-134024668	Caco-2	colon:	n/a
30	chr2:134023662-134023712	AG04449	skin:	fetal
31	chr2:134024459-134024509	NB4	blood:	n/a
32	chr2:134023662-134023712	HEEpiC	esophagus:	n/a
33	chr2:134024459-134024509	GM12891	blood:	n/a
34	chr2:134023662-134023712	H1-hESC	embryonic stem cell:	embryo
35	chr2:134024266-134024316	GM12892	blood:	n/a
36	chr2:134024618-134024668	BJ	skin:	n/a
37	chr2:134024459-134024509	HEK293	kidney:	embryo
38	chr2:134024093-134024143	BJ	skin:	n/a
39	chr2:134023662-134023712	NB4	blood:	n/a
40	chr2:134024266-134024316	PFSK-1	brain:	n/a
41	chr2:134024418-134024468	HRE	kidney:	n/a
42	chr2:134024418-134024468	HCPEpiC	choroid plexus:	n/a
43	chr2:134023662-134023712	BE2_C	brain:	n/a
44	chr2:134023662-134023712	PrEC	prostate:	n/a
45	chr2:134023662-134023712	NT2-D1	testis:	n/a
46	chr2:134024459-134024509	AG04450	lung:	fetal
47	chr2:134024459-134024509	HCF	heart:	n/a
48	chr2:134024418-134024468	AoSMC	blood vessel:	n/a
49	chr2:134024418-134024468	AG09319	gingival:	n/a
50	chr2:134024459-134024509	HEEpiC	esophagus:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:18793804..18794673-chr2:134023005..134023895,2	Hela-S3	cervix:
2	chr1:154946346..154946996-chr2:134023337..134024323,2	Hela-S3	cervix:
3	chr16:30709997..30710818-chr2:134023319..134023932,2	Hela-S3	cervix:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GPR39-4	chr2:134024845-134024996	NR_110294
2	lnc-GPR39-4	chr2:134023767-134023868	ENSG00000226953
3	lnc-GPR39-4	chr2:134023767-134023868	NR_110294
4	lnc-GPR39-4	chr2:134024845-134024996	ENSG00000226953
5	lnc-GPR39-4	chr2:134023814-134024008	ENSG00000226953.3
6	lnc-GPR39-4	chr2:134024845-134024996	ENSG00000226953
7	lnc-GPR39-4	chr2:134024845-134024996	ENSG00000226953.3

No data

Variant related genes	Relation type
ENSG00000226953	TF binding region
ENSG00000226953	CpG island
ENSG00000105662	chromatin interactions
ENSG00000261840	chromatin interactions
ENSG00000160691	chromatin interactions
ENSG00000080603	chromatin interactions
NFKB1	miRNA target sites
SMCR7L	miRNA target sites
ATOX1	miRNA target sites

Extended variants
information (count: 62 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:62 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs150193626	chr2:134023625-134023626	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs538312187	chr2:134023626-134023627	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs553458541	chr2:134023639-134023640	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs571659236	chr2:134023661-134023662	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs542253575	chr2:134023694-134023695	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs554587380	chr2:134023713-134023714	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs576238509	chr2:134023744-134023745	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs192709445	chr2:134023745-134023746	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs373391952	chr2:134023765-134023766	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs6710084	chr2:134023766-134023767	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs532359058	chr2:134023798-134023799	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
12	rs149327590	chr2:134023824-134023825	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
13	rs185160167	chr2:134023841-134023842	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
14	rs528352759	chr2:134023844-134023845	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
15	rs560567226	chr2:134023848-134023849	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
16	rs527827187	chr2:134023948-134023949	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs549093813	chr2:134023978-134023979	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs376349318	chr2:134023985-134023986	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs531882930	chr2:134023994-134023995	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs550076301	chr2:134023999-134024000	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs571465722	chr2:134024008-134024009	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs538848591	chr2:134024014-134024015	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs144584213	chr2:134024020-134024021	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs372128399	chr2:134024036-134024037	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs565425971	chr2:134024049-134024050	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs536378327	chr2:134024077-134024078	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs138136745	chr2:134024120-134024121	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs576006820	chr2:134024122-134024123	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs536909849	chr2:134024172-134024173	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs558896116	chr2:134024201-134024202	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs76481368	chr2:134024256-134024257	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs77255099	chr2:134024263-134024264	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs559622159	chr2:134024271-134024272	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs572427252	chr2:134024300-134024301	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs143622251	chr2:134024415-134024416	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs561091640	chr2:134024566-134024567	Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
37	rs114303232	chr2:134024688-134024689	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs543084944	chr2:134024701-134024702	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs565233712	chr2:134024734-134024735	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs532705999	chr2:134024748-134024749	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs558483599	chr2:134024758-134024759	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs188996373	chr2:134024818-134024819	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs370322763	chr2:134024822-134024823	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs566287697	chr2:134024832-134024833	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs535936066	chr2:134024834-134024835	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs192427384	chr2:134024839-134024840	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs138296197	chr2:134024872-134024873	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
48	rs377667829	chr2:134024873-134024874	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
49	rs140406334	chr2:134024884-134024885	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
50	rs537042994	chr2:134025073-134025074	Bivalent/Poised TSS Enhancers Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Developmental delay	21147756	CNVD
Mental retardation	17621639	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Breast cancer	21509527	CNVD
Mental retardation	17124404	CNVD
Colorectal cancer	20459617	CNVD
Neuroticism	17667963	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:264 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:133994000-134023600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr2:134020600-134023600	Enhancers	NHDF-Ad	bronchial
3	chr2:134022200-134023600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr2:134022200-134023600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr2:134022400-134023800	Weak transcription	Fetal Kidney	kidney
6	chr2:134022400-134024000	Flanking Active TSS	Brain Hippocampus Middle	brain
7	chr2:134022400-134024200	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
8	chr2:134022600-134023600	Active TSS	iPS-20b Cell Line	embryonic stem cell
9	chr2:134022600-134024000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
10	chr2:134022600-134024400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr2:134022800-134023600	Weak transcription	NHLF	lung
12	chr2:134022800-134023800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr2:134022800-134023800	Enhancers	HUVEC	blood vessel
14	chr2:134022800-134024000	Flanking Active TSS	Brain Cingulate Gyrus	brain
15	chr2:134022800-134024200	Active TSS	Brain Substantia Nigra	brain
16	chr2:134022800-134024400	Active TSS	Placenta	Placenta
17	chr2:134022800-134025000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
18	chr2:134022800-134025000	Enhancers	Fetal Heart	heart
19	chr2:134022800-134025000	Active TSS	Hela-S3	cervix
20	chr2:134022800-134025200	Active TSS	Pancreatic Islets	Pancreatic Islet
21	chr2:134023000-134023600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
22	chr2:134023000-134023600	Active TSS	Fetal Lung	lung
23	chr2:134023000-134023800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr2:134023000-134023800	Enhancers	Fetal Brain Male	brain
25	chr2:134023000-134023800	Enhancers	Pancreas	Pancrea
26	chr2:134023000-134023800	Enhancers	NH-A	brain
27	chr2:134023000-134024000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr2:134023000-134024000	Flanking Active TSS	Brain Germinal Matrix	brain
29	chr2:134023000-134024200	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr2:134023000-134024400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr2:134023000-134024400	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
32	chr2:134023000-134024400	Active TSS	Rectal Smooth Muscle	rectum
33	chr2:134023000-134024400	Bivalent Enhancer	Stomach Mucosa	stomach
34	chr2:134023000-134024800	Active TSS	Left Ventricle	heart
35	chr2:134023000-134024800	Active TSS	Skeletal Muscle Female	skeletal muscle
36	chr2:134023000-134025000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
37	chr2:134023000-134025000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
38	chr2:134023000-134025200	Active TSS	H9 Cell Line	embryonic stem cell
39	chr2:134023000-134025200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
40	chr2:134023000-134025200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
41	chr2:134023000-134025200	Active TSS	iPS-15b Cell Line	embryonic stem cell
42	chr2:134023000-134025200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr2:134023200-134023600	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr2:134023200-134023600	Active TSS	Gastric	stomach
45	chr2:134023200-134023600	Active TSS	Rectal Mucosa Donor 31	rectum
46	chr2:134023200-134023600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
47	chr2:134023200-134023600	Active TSS	Osteobl	bone
48	chr2:134023200-134023800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr2:134023200-134023800	Active TSS	Duodenum Mucosa	Duodenum
50	chr2:134023200-134023800	Enhancers	Esophagus	oesophagus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links